다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Y mAbs Therapeutics Inc (YMAB)
Y mAbs Therapeutics Inc (YMAB) 뉴스

YMAB

Y mAbs Therapeutics (YMAB)

Y mAbs Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:YMAB

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	05:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/05/08	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/05/08	05:05	GlobeNewswire Inc.	Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/04/26	20:05	GlobeNewswire Inc.	Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/04/26	05:05	GlobeNewswire Inc.	Y-mAbs to Present at 2024 ASCO Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/14	22:05	GlobeNewswire Inc.	Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/08	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/08	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/08	06:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/07	06:49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/07	06:40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/06	09:05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/04	21:30	GlobeNewswire Inc.	Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/04	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/01	07:04	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/01	06:05	GlobeNewswire Inc.	Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/03/01	06:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/02/16	21:30	GlobeNewswire Inc.	Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/02/15	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/02/07	05:59	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/01/23	08:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/01/23	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/01/23	07:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/01/23	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/01/23	07:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/01/23	07:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/01/23	07:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/01/09	20:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/01/03	06:05	GlobeNewswire Inc.	Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2023/12/27	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc

검색 관련기사 보기:NASDAQ:YMAB

1 2 3 4 5 6 7 8 9 10 다음 >>

Low Carbon 100 Europe

Sequoia Financial

Federal Home Loan Mortgage (QB)

GSR II Meteora Acquisition

BEEFQ850 Ex:8,5

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관